Cargando…

Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová

BACKGROUND: During the COVID-19 pandemic, most settings experienced healthcare service disruptions. The majority of cytological screening procedures were postponed to focus on assisting patients infected with COVID-19. In this study, we aimed to analyse the impact of the impact of the COVID-19 pande...

Descripción completa

Detalles Bibliográficos
Autores principales: Melichova, J, Marusakova, E, Bilikova, L, Sivčo, P, Plancikova, D, Hazerova, D, Pham, T, Paulik, S, Putekova, S, Majdan, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620085/
http://dx.doi.org/10.1093/eurpub/ckac129.255
_version_ 1784821310518460416
author Melichova, J
Marusakova, E
Bilikova, L
Sivčo, P
Plancikova, D
Hazerova, D
Pham, T
Paulik, S
Putekova, S
Majdan, M
author_facet Melichova, J
Marusakova, E
Bilikova, L
Sivčo, P
Plancikova, D
Hazerova, D
Pham, T
Paulik, S
Putekova, S
Majdan, M
author_sort Melichova, J
collection PubMed
description BACKGROUND: During the COVID-19 pandemic, most settings experienced healthcare service disruptions. The majority of cytological screening procedures were postponed to focus on assisting patients infected with COVID-19. In this study, we aimed to analyse the impact of the impact of the COVID-19 pandemic on the uptake of cervical cancer screening in Slovakia. METHODS: Data on cytological screening procedures were obtained from two of the three health insurance companies in Slovakia for the years 2019 and 2020, covering the population of women aged 15 and older. All data were calculated stratified for age groups. Rates of cytological screenings were calculated as the number of procedures per women registered in the insurance company in the same age group and rate ratios were calculated as ratios of the rates for the years 2020 and 2019 for the same age group. Incidence rates were calculated as the number of newly diagnosed cervical cancer cases per women registered in the insurance company in the respective year. RESULTS: Rate ratios of cytological screening procedures revealed that in both examined health insurance companies, the rate of cytological exams was lower in 2020 compared to 2019 (0.95 and 0.89). This was observed across all age groups. The results showed a clear and statistically significant age gradient, indicating that the level of disruption increased with age. The age group 60-69 years had the highest incidence rate of cervical cancer in 2019, at 54.3 per 100 000. In 2020, the highest rate was 48.3 in the age group 50-59 years. The lowest rates were in children and young adults (<20 years). CONCLUSIONS: This study confirms the significant impact of the pandemic on cervical cancer screening uptake in Slovakia, which may have delayed the diagnosis of cervical cancer into later stages of the disease with a worse prognosis. This may lead to increased mortality and years lived with disability due to this disease in Slovakia. KEY MESSAGES: • Disruptions in cervical cancer screenings were observed in Slovakia during the COVID-19 pandemic which may result in an increase in cervical cancer incidence and mortality. • Strategies should be implemented to maintain cancer screening programs during health emergencies to avoid excessive mortality and morbidity.
format Online
Article
Text
id pubmed-9620085
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96200852022-11-04 Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová Melichova, J Marusakova, E Bilikova, L Sivčo, P Plancikova, D Hazerova, D Pham, T Paulik, S Putekova, S Majdan, M Eur J Public Health Parallel Programme BACKGROUND: During the COVID-19 pandemic, most settings experienced healthcare service disruptions. The majority of cytological screening procedures were postponed to focus on assisting patients infected with COVID-19. In this study, we aimed to analyse the impact of the impact of the COVID-19 pandemic on the uptake of cervical cancer screening in Slovakia. METHODS: Data on cytological screening procedures were obtained from two of the three health insurance companies in Slovakia for the years 2019 and 2020, covering the population of women aged 15 and older. All data were calculated stratified for age groups. Rates of cytological screenings were calculated as the number of procedures per women registered in the insurance company in the same age group and rate ratios were calculated as ratios of the rates for the years 2020 and 2019 for the same age group. Incidence rates were calculated as the number of newly diagnosed cervical cancer cases per women registered in the insurance company in the respective year. RESULTS: Rate ratios of cytological screening procedures revealed that in both examined health insurance companies, the rate of cytological exams was lower in 2020 compared to 2019 (0.95 and 0.89). This was observed across all age groups. The results showed a clear and statistically significant age gradient, indicating that the level of disruption increased with age. The age group 60-69 years had the highest incidence rate of cervical cancer in 2019, at 54.3 per 100 000. In 2020, the highest rate was 48.3 in the age group 50-59 years. The lowest rates were in children and young adults (<20 years). CONCLUSIONS: This study confirms the significant impact of the pandemic on cervical cancer screening uptake in Slovakia, which may have delayed the diagnosis of cervical cancer into later stages of the disease with a worse prognosis. This may lead to increased mortality and years lived with disability due to this disease in Slovakia. KEY MESSAGES: • Disruptions in cervical cancer screenings were observed in Slovakia during the COVID-19 pandemic which may result in an increase in cervical cancer incidence and mortality. • Strategies should be implemented to maintain cancer screening programs during health emergencies to avoid excessive mortality and morbidity. Oxford University Press 2022-10-25 /pmc/articles/PMC9620085/ http://dx.doi.org/10.1093/eurpub/ckac129.255 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Melichova, J
Marusakova, E
Bilikova, L
Sivčo, P
Plancikova, D
Hazerova, D
Pham, T
Paulik, S
Putekova, S
Majdan, M
Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title_full Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title_fullStr Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title_full_unstemmed Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title_short Disruptions of cytological screening procedures due to the COVID-19 pandemic in Slovakia: Juliana Melichová
title_sort disruptions of cytological screening procedures due to the covid-19 pandemic in slovakia: juliana melichová
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620085/
http://dx.doi.org/10.1093/eurpub/ckac129.255
work_keys_str_mv AT melichovaj disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT marusakovae disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT bilikoval disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT sivcop disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT plancikovad disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT hazerovad disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT phamt disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT pauliks disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT putekovas disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova
AT majdanm disruptionsofcytologicalscreeningproceduresduetothecovid19pandemicinslovakiajulianamelichova